Navigation Links
Jump-starting T Cells In Skin Cancer

Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins. How these vaccines work and why they are only effective in some patients remains unclear. Pierre Coulie and colleagues now show, in two articles in the January 17 issue of the Journal of Experimental Medicine, that these vaccines work by increasing the number of immune cells called killer T cells that can attack the tumor. In an unexpected finding, however, they discovered that that these cells mostly recognize tumor proteins that were not contained in the vaccine. Understanding the characteristics of the T cell populations that are expanded after vaccination may help in the development of more effective anti-tumor vaccines.

Tumor-specific T cells can be detected in the blood and the tumors of many melanoma patients, and yet these cells are unable to kill the tumor. What causes the impotence of these T cells is a mystery. Equally mysterious is why vaccination against tumor-specific proteins sometimes causes tumor regression without expanding large numbers of vaccine-specific killer T cells.

Pierre Coulie's group studied anti-tumor T cells in patients vaccinated with a tumor antigen called MAGE-3. In one patient whose tumor regressed after vaccination, the authors found significantly more T cells specific for non-vaccine tumor proteins than were detected before vaccination. Vaccine-specific T cells, on the other hand, became detectable but did not expand to large numbers. Thus, reinvigoration of existing tumor-specific T cells after vaccination did not require large numbers of vaccine-specific T cells.

Although it is not known how these tumor-specific cells get activated, Coulie thinks that the few T cells stimulated by the vaccine may change the local, suppressive environment of the tumor such that other T cells can snap out of their stupor and attack the tumor.


'"/>

Source:Journal of Experimental Medecine


Page: 1

Related biology news :

1. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
2. Transplantation Of Monkey Embryonic Stem Cells Reverses Parkinson Disease In Primates
3. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
4. Weill Cornell Research Reveals Secrets Of Trafficking Within Cells
5. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
6. Placenta Is A Rich Source Of Blood Stem Cells
7. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
8. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells
9. Protein That Promotes Survival Of Stem Cells Might Be Key To Poor Leukemia Prognosis
10. Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells
11. Human Cells Filmed Instantly Messaging for First Time

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Jump starting Cells Skin Cancer

(Date:11/20/2009)...t: Toxins in coal-tar-based sealcoats in parking l... according to a USGS study. PAHs or polycyclic a... oil, coal and tar deposits, and can have toxic ef...und in house dust; however, the specific sources o... found that dust from indoor areas near parking lo...
(Date:11/20/2009)...ive pulmonary disease (COPD), a respiratory diseas...a, is the fourth leading cause of death worldwide....archers have yet to find any real treatment or cur...The University of Western Ontario in London, Canad... insight into the disease. , Parraga is a sc...
(Date:11/19/2009)...tter ants, which cultivate fungus for food, have m... add to the list: the ant farmers, like their huma... to make their gardens grow. The finding, reported...uments a previously unknown symbiosis between ants...utter ants have come to dominate the American trop...
Breaking Biology News(10 mins):From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Gaining a better picture of lung disease 2Like humans, ants use bacteria to make their gardens grow 2Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 1Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 2Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 3Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 4Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 5Dysport proves safe effective anti wrinkle treatment UT Southwestern plastic surgeons find 53439 1Dysport proves safe effective anti wrinkle treatment UT Southwestern plastic surgeons find 53439 2Savient Pharmaceuticals Receives Complete Response Letter from U S Food and Drug Administration for KRYSTEXXA 28TM 29 53436 1Savient Pharmaceuticals Receives Complete Response Letter from U S Food and Drug Administration for KRYSTEXXA 28TM 29 53436 2Savient Pharmaceuticals Receives Complete Response Letter from U S Food and Drug Administration for KRYSTEXXA 28TM 29 53436 3Savient Pharmaceuticals Receives Complete Response Letter from U S Food and Drug Administration for KRYSTEXXA 28TM 29 53436 4Savient Pharmaceuticals Receives Complete Response Letter from U S Food and Drug Administration for KRYSTEXXA 28TM 29 53436 5Savient Pharmaceuticals Receives Complete Response Letter from U S Food and Drug Administration for KRYSTEXXA 28TM 29 53436 6
... The genetic alphabet contains four letters. Alt...olecules, it isnt so easy for us to read a DNA seq...x, highly sophisticated analytical techniques to c...team at the Institute for Analytical Sciences (ISA...at could provide a way to directly sequence DNA. T...
...studies published in the current issue of CELL TRA...nefit from human mesenchymal stem cell (hMSC) or b...n both studies, the migration of chemically tagged... the degree to which the transplanted cells reache...cally active. , Tracking transplanted hMSCs to i...
...nced the speakers for the New and Notable Symposiu...and the International Biophysics Congress in Long ...nd notable symposium highlights the latest and mos...e nominated and selected by the Societys program c...ruary 5, 2008 from 4:00-6:00 PM in Ballroom 1 of t...
Other Biology News:Genetic material under a magnifying glass 2Stroke victims may benefit from stem cell transplants 2Biophysical Society announces new and notable symposium speakers 2
(Date:11/20/2009)...TTLE, Nov. 20 Cell Thera...ed today that the Ninth Circuit Court of Appeals r... CTI should be allowed to pursue all of its claims...the District Court for trial. CTI filed a complai...y reimbursement consultant for CTI,s product TRISE...
(Date:11/19/2009)..., Nov. 19 Omeros Corpora...nancial results for the third quarter ended Septem... 30, 2009, Omeros reported a net loss of $3.9 mill... of $7.4 million, or $2.54 per share, for the same...er 30, 2009, the Company reported a net loss of $1...
(Date:11/19/2009)...VERN, Pa. and WALTHAM, Mass., Nov. 19 /PRNewswire/... Resources find that the leading driver of antibio... broad-spectrum activity against gram-positive and...ganisms that can cause nosocomial pneumonia, surve...arily for agents that provide appropriate coverage...
(Date:11/19/2009)... InSound is honored by latest award for rev... Newark, CA (PRWEB) November 16, 2009 -- Popular S...le” hearing aid from InSound Medical a winne... the Health category.    Chose... reside deep in the hearing canal for up to four m...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
...APEL HILL, N.C., Oct. 20 With limited information...oward support of Continuing,Medical Education acti...device industry executives are anxious to understa...uring investments provide appropriate impact,on he...es. In the recently,published report by benchmarki...
...DIANAPOLIS, Oct. 20 The Board of Directors,of Eli...as R. Oberhelman as a,new member, effective Decemb...group president of Caterpillar Inc. and is a membe...f Lilly,s board, Oberhelman will serve on,both the... will stand for,election by Lilly shareholders at ...
...NNAPOLIS, N.C., Oct. 20 Academia, science, indust...Monday, October 20th at 10,AM at the Dedication an...Core Laboratory Building, the UNC Nutrition Resear...cience Institute Building. The UNC Nutrition,Resea...ral University, UNC,Chapel Hill and UNC Greensboro...
Other Biology Technology:Bio-Pharma Industry Improves Patient Outcomes Through Continuing Medical Education (CME) 2Douglas Oberhelman Elected to Lilly Board of Directors 2Douglas Oberhelman Elected to Lilly Board of Directors 3Campus Celebrates Historic Milestone 2Campus Celebrates Historic Milestone 3Campus Celebrates Historic Milestone 4Campus Celebrates Historic Milestone 5
...e monoclonal [1320] to RFC1 Immunogen Recombinan...n Replication Factor C expressed in E. coli. Reac...S. cerevisiae. Not yet tested in other species. Th...ackground Information Replication factor C is a m...
MetaMorph from Universal Imaging Corporation (a subsidiary of Molecular Devices)
...sULTRA imaging system from Molecular Devices is a...tem for automated acquisition and analysis of imag...eXpressULTRA is powered by MetaXpress, a complete ... storage and analysis. MetaXpress enables users to...
Varian 2200 Ion Trap GC/MS from Varian, Inc.
Biology Products: